Article ID Journal Published Year Pages File Type
10918132 Radiotherapy and Oncology 2015 6 Pages PDF
Abstract
The combination of Endostar with CCRT for locally advanced NSCLC patients was feasible and showed promising survival and local control rates.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer
Authors
, , , , , , , , , , , , , , , ,